NCT02633514View on ClinicalTrials.gov

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

PHASE3RecruitingINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2026

Conditions

Thymoma and Thymic Carcinoma

Interventions

DRUG

Cisplatin

25mg/m2,iv gtt,d1-3

DRUG

Etoposide

75mg/m2,iv gtt,d1-3

RADIATION

radiotherapy

60Gy/30Fx

Trial Locations (1)

20032

RECRUITING

Kailiang Wu, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER